| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/29/2009 | EP2083071A1 Medium for propagating and expanding stem cells |
| 07/29/2009 | EP2083018A2 Compositions and methods relating to STOP-1 |
| 07/29/2009 | EP2082749A2 Prevention and treatment of Alzheimer's disease |
| 07/29/2009 | EP2082052A2 Knockout mice for pro1105, pro1279 or pro1783 coding genes |
| 07/29/2009 | EP2082036A2 In vivo transformation of pancreatic acinar cells into insulin-producing cells |
| 07/29/2009 | EP2082032A1 Hybridomas producing antibodies against non functional p2x7 receptor |
| 07/29/2009 | EP2082031A2 Composition for preserving reproductive cells and mehod of using |
| 07/29/2009 | EP2082030A2 Devices with cells cultured on flexible supports |
| 07/29/2009 | EP2081962A2 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
| 07/29/2009 | EP2081585A2 Cancer treatment |
| 07/29/2009 | EP1636348B1 Method of generating islet beta-cells from exocrine pancreatic cells |
| 07/29/2009 | EP1484395B1 Transposon being functional in mammals |
| 07/29/2009 | EP1432441B1 Use of hmgb1 for the activation of dendritic cells |
| 07/29/2009 | EP1292676B1 Mutation associated with epilepsy |
| 07/29/2009 | EP1283868B1 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 07/29/2009 | EP1086223B1 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/29/2009 | EP1036327B1 HLA-E binding to CD94/NKG2+ cells |
| 07/29/2009 | CN101495623A Method to modulate hematopoietic stem cell growth |
| 07/29/2009 | CN101495622A Genetically modified plants which synthesize a starch havingincreased swelling power |
| 07/29/2009 | CN101495621A Novel hepatocyte-like cells and hepatoblast-like cells derived from HBS cells |
| 07/29/2009 | CN101495620A Method of proliferating LAK cell |
| 07/29/2009 | CN101495619A Determination of a change in a cell population |
| 07/29/2009 | CN101495618A Peroxisome proliferator-activator receptor delta (PPAR delta) and the development of preimplantation embryos |
| 07/29/2009 | CN101492656A Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium |
| 07/29/2009 | CN101492655A Vascularized fat depot based on partition and construction method thereof |
| 07/29/2009 | CN101492654A Method for using umbilical stalk placenta to prepare mesenchyma stem cell |
| 07/29/2009 | CN101492653A Cultivation method for rat venae cavae smooth muscle cell |
| 07/29/2009 | CN101491703A Vitro tissue culturing method and multi-pore carrier |
| 07/29/2009 | CN100519751C Optimization of cell for endogenous gene activation |
| 07/29/2009 | CN100519749C Agonist anti-TRK-C monoclonal antibodies |
| 07/29/2009 | CN100519742C Ultra-low temperature preservation solution for animal cells and preserving method |
| 07/29/2009 | CN100519741C Extract of egg celsl from animals |
| 07/28/2009 | US7566821 Soybean variety D4422801 |
| 07/28/2009 | US7566820 Soybean variety D4208814 |
| 07/28/2009 | US7566813 Transgenic soybean seeds exhibiting an oil composition comprising 55 to 80% by weight oleic acid, 10 to 40% by weight linoleic acid, 6% or less by weight linolenic acid, and 2 to 8% by weight saturated fatty acids for use in ehancing applicability in food, biodiesel and biolube markets |
| 07/28/2009 | US7566774 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 07/28/2009 | US7566764 Truncated BARD1 protein, and its diagnostic and therapeutic uses |
| 07/28/2009 | US7566568 Method for generating highly active human dendritic cells from peripheral blood mononuclear cells |
| 07/28/2009 | US7566567 nontumorigenic, virally-immortalized human hepatocyte cell lines, that can be maintained in serum-free media, and produce endogenous plasma proteins, such as albumin, alpha -1 antitrypsin, blood clotting factors VIII and IX, |
| 07/28/2009 | US7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 07/28/2009 | US7566565 eukaryotic cell containing a first expression vector encoding a proprotein of Factor IX (proFIX), or a fusion protein of proFIX, and a second expression vector encoding a functional polypeptide PC5; precursor polypeptide for a Factor IX-Fc monomer-dimer hybrid; culturing |
| 07/28/2009 | US7566560 Polypeptides and expression vectors host cell and transgenic plants with nucleic acid and stress resistance; antifungal agent |
| 07/28/2009 | US7566559 Human cyclin-dependent kinase (hPNQALRE) |
| 07/28/2009 | US7566552 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/28/2009 | US7566539 Anti-CCR2 antibodies and methods of use therefor |
| 07/28/2009 | US7566535 Enhanced oligonucleotide-mediated nucleic acid sequence alteration |
| 07/28/2009 | US7566530 Method for detecting PrP using at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand |
| 07/28/2009 | US7566450 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders |
| 07/28/2009 | CA2316447C Rantes mutants and therapeutic applications thereof |
| 07/23/2009 | WO2009092092A1 Stem cell aggregates and methods for making and using |
| 07/23/2009 | WO2009092087A2 Selective differentiation, identification, and modulation of human th17 cells |
| 07/23/2009 | WO2009092009A2 Modulating light response pathways in plants |
| 07/23/2009 | WO2009092005A2 Methods of generating cardiomyocytes and cardiac progenitors and compositions |
| 07/23/2009 | WO2009091659A2 Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents |
| 07/23/2009 | WO2009091054A1 Novel hydrogen peroxide-forming nadh oxidase, and dna encoding the same |
| 07/23/2009 | WO2009090787A1 Method for producing bioactive peptide or protein and recombinant animal cell |
| 07/23/2009 | WO2009090424A1 Cell culture system for pancreatic islands |
| 07/23/2009 | WO2009090190A1 Mouse models carrying a knock-out mutation of the glutaminyl cyclase gene |
| 07/23/2009 | WO2009045360A3 Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
| 07/23/2009 | WO2009035612A8 Multilineage-inducible cells and uses thereof |
| 07/23/2009 | WO2009027106A3 Non-invasive in vivo imaging and methods for treating type i diabetes |
| 07/23/2009 | WO2009017460A8 Method for identifying and selecting cardiomyocytes |
| 07/23/2009 | WO2009014462A8 Methods and polynucleotides for improving plants |
| 07/23/2009 | WO2009004664A8 Immortalized cell line of murine mesenchymal stem cells, method for preparation and uses thereof |
| 07/23/2009 | WO2008133684A8 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 07/23/2009 | WO2008051949A8 Gpr125 as a marker for stem and progenitor cells and methods use thereof |
| 07/23/2009 | WO2008041863A8 Novel genes and polypeptides associated with insecticidal activity |
| 07/23/2009 | WO2008015662A8 A method of producing recombinant biological products |
| 07/23/2009 | WO2007148971A8 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells |
| 07/23/2009 | WO2007147014A8 Method and systems for using biopolymer-based beads and hydrogels |
| 07/23/2009 | WO2007143701A8 Monoclonal antibodies that potently neutralize hepatitis c virus (hcv) of diverse genotypes |
| 07/23/2009 | WO2007137300A8 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods |
| 07/23/2009 | WO2007133822A8 Gitr antibodies for the treatment of cancer |
| 07/23/2009 | WO2007110867A8 Implantable sensor |
| 07/23/2009 | WO2007109648A8 Compositions and methods for modulating store-operated calcium entry |
| 07/23/2009 | WO2007106707A8 Identification and engineering of antibodies with variant heavy chains and methods of using same |
| 07/23/2009 | US20090188010 Insect Chymotrypsin and Inhibitors Thereof |
| 07/23/2009 | US20090188009 Heat shock rna from various species and its use in activation of heat shock transcription factor, in treatment of various diseases in animals and in generation of stress-resistant plants |
| 07/23/2009 | US20090188008 Compositions and methods for the suppression of target polynucleotides |
| 07/23/2009 | US20090188006 Pathogen-inducible synthetic promoter |
| 07/23/2009 | US20090188004 Protein Kinase Stress-Related Proteins and Methods of Use in Plants |
| 07/23/2009 | US20090188001 Sucrose Biosensors and Methods of Using the Same |
| 07/23/2009 | US20090188000 Gene family (lbfl313) associated with pancreatic cancer |
| 07/23/2009 | US20090187997 Cre-lox based gene knockdown constructs and methods of use thereof |
| 07/23/2009 | US20090186917 6-And 7-amino isoquinoline compounds and methods for making and using the same |
| 07/23/2009 | US20090186910 Compositions and methods for reducing cellular fat and for predicting cardiac toxicity and upon treatment with tyrosine kinase inhibitors |
| 07/23/2009 | US20090186907 Pyrazinones As Cellular Proliferation Inhibitors |
| 07/23/2009 | US20090186894 N-Substituted-Heterocycloalkyloxybenzamide Compounds and Methods of Use |
| 07/23/2009 | US20090186846 Methods to reprogram splice site selection in pre-messenger RNAs |
| 07/23/2009 | US20090186845 Interfering rna molecules |
| 07/23/2009 | US20090186843 RNA sequence-specific mediators of RNA interference |
| 07/23/2009 | US20090186824 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/23/2009 | US20090186822 Thrombopoietic Compounds |
| 07/23/2009 | US20090186820 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 07/23/2009 | US20090186816 Polypeptide targeting to mitochondria |
| 07/23/2009 | US20090186812 Apo-2 ligand |
| 07/23/2009 | US20090186806 Truncated Activin Type II Receptor and Methods of Use |
| 07/23/2009 | US20090186805 Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance |
| 07/23/2009 | US20090186768 Sunscreen formulations for use in the production of organic crops |
| 07/23/2009 | US20090186764 Eukaryotic translation initiation factor gene regulatory elements for use in plants |